5th Annual Pharmaceutical and Biotech Medical Affairs Pre-Launch Strategies Conference

April 8-9, 2020 | Boston, MA

5th Annual Pharmaceutical and Biotech Medical Affairs Pre-Launch Strategies Conference
April 8-9, 2020 | Boston, MA

Access Agenda

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

“I very much enjoyed working with you on this meeting and I found it very interesting especially as there was a very high level of interaction from the audience.”

Senior Medical Affairs Director
Celgene

“Great insight to hear payer perspective in contracting and account management and the changing healthcare landscape.”

Channel Liaison
Biogen

“It was definitely an excellent well-rounded opportunity to meet new people, get new ideas, and get an in-depth education on what’s to come with the FDA collaborations.”

Quality Engineer
Centurion Medical Products

“It was very well organized event and high quality, the fact to have an IVD track was also interesting. Thanks, I will recommend the Q1 event!”

Regulatory Affairs – EMEA Regional Head
BIOMERIEUX

“The organization and support staff were fantastic! I’m looking forward to next year.”

Global Business Project Lead
Genentech

About the Conference:

Pre-launch medical affairs activities build a foundation for new product launches, providing a scientific and medical narrative disseminated to healthcare professionals, payers and additional stakeholders to support the health and economic benefits of new products. Whether the launch focuses on a new product iteration of an existing approved therapy, or an entirely new therapy, medical affairs executives must build comprehensive support for new products through the leverage of key opinion leaders, medical science liaisons, and commercial teams, ensuring all stakeholders both internally and externally are presented with relevant new product data in a timeline which supports the ultimate launch.

Core Topics to be Addressed:

  • Creation of a scientific narrative to support launch
  • Use of real-world evidence in pre-launch programs
  • Pre-launch collaboration with payer stakeholders
  • Leverage of KOLs & emergence of digital KOLs
  • Merging pre-launch medical affairs with commercial

Program Highlights:

  • Mix of presenters from companies large to small
  • External stakeholder participation: Payer perspectives
  • Focus on practical, real-world solutions to pre-launch
  • Collaborative sessions focused on hands-on learning

Core Topics to be Addressed:

  • Creation of a scientific narrative to support launch
  • Use of real-world evidence in pre-launch programs
  • Pre-launch collaboration with payer stakeholders
  • Leverage of KOLs & emergence of digital KOLs
  • Merging pre-launch medical affairs with commercial

Access Agenda

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

Audience

75 Attendees

All attendees come directly from pharmaceutical and biotech companies

Distinguished Presenters

23 Speakers

Networking

Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices

Share This